yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q28255051-77F7E04E-3294-49F0-B69A-839F4EF1BC9E
Q28255051-77F7E04E-3294-49F0-B69A-839F4EF1BC9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28255051-77F7E04E-3294-49F0-B69A-839F4EF1BC9E
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatm
P2860
Q28255051-77F7E04E-3294-49F0-B69A-839F4EF1BC9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28255051-77F7E04E-3294-49F0-B69A-839F4EF1BC9E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f0ff7ef29db95693802a69ee5288dc46eabb9071
P2860
Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis.